Furthermore, the convergence of wearable glucose monitors with automated insulin delivery systems represents a notable stride in diabetes management, facilitating continuous monitoring of blood glucose levels and responsive insulin administration [91]. The gene discussed is INS; the disease is diabetes mellitus.